JP Morgan Chase
IPSC icon

JP Morgan Chase’s Century Therapeutics IPSC Stock Holding History

JP Morgan Chase’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
51,208
+51,093
+44,429% +$117K ﹤0.01% 5898
2026
Q1 		$233 Sell
115
-2,962
-96% -$6.23K ﹤0.01% 7241
2025
Q4 		$3.06K Buy
3,077
+1,484
+93% +$905 ﹤0.01% 6881
2025
Q3 		$793 Sell
1,593
-1,044
-40% -$563 ﹤0.01% 7007
2025
Q2 		$1.47K Sell
2,637
-66,853
-96% -$35.9K ﹤0.01% 6575
2025
Q1 		$33.1K Sell
69,490
-93,699
-57% -$70.4K ﹤0.01% 6007
2024
Q4 		$165K Buy
163,189
+91,468
+128% +$125K ﹤0.01% 5563
2024
Q3 		$123K Buy
71,721
+51,664
+258% +$101K ﹤0.01% 5615
2024
Q2 		$51.1K Sell
20,057
-5,623
-22% -$17.8K ﹤0.01% 5852
2024
Q1 		$107K Buy
25,680
+10,498
+69% +$44.4K ﹤0.01% 5641
2023
Q4 		$50.4K Sell
15,182
-11,341
-43% -$20.7K ﹤0.01% 5998
2023
Q3 		$53K Buy
26,523
+5,807
+28% +$15.4K ﹤0.01% 5784
2023
Q2 		$65.5K Sell
20,716
-45,036
-68% -$145K ﹤0.01% 5644
2023
Q1 		$228K Buy
65,752
+291
+0.4% +$1.28K ﹤0.01% 4988
2022
Q4 		$335K Buy
65,461
+2,360
+4% +$22.3K ﹤0.01% 4760
2022
Q3 		$624K Sell
63,101
-2,255
-3% -$23.7K ﹤0.01% 4317
2022
Q2 		$548K Buy
65,356
+6,237
+11% +$61.2K ﹤0.01% 4495
2022
Q1 		$744K Sell
59,119
-81,834
-58% -$1.08M ﹤0.01% 4459
2021
Q4 		$2.23M Buy
140,953
+77,529
+122% +$1.46M ﹤0.01% 3775
2021
Q3 		$1.6M Buy
+63,424
New +$1.72M ﹤0.01% 3954

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

JP Morgan Chase's IPSC Position: Q2 2026 in Review

JP Morgan Chase increased its Century Therapeutics (IPSC) stake by 44,429% in Q2 2026, buying an estimated $117K and bringing the position to 51,208 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #5898.

JP Morgan Chase first reported a position in IPSC in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.23M in Q4 2021. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • JP Morgan Chase held 51,208 shares of Century Therapeutics worth $123K as of Q2 2026.
  • JP Morgan Chase bought 51,093 Century Therapeutics shares in Q2 2026, an estimated $117K.
  • Century Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5898 holding.
  • JP Morgan Chase first reported a position in Century Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Century Therapeutics position peaked at $2.23M in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.